跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Angitrim - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Angitrim
Approved
STANDARD
Angitrim
Stallion Laboratories Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2326b6263b00de12
Company
Stallion Laboratories Pvt. Ltd
Type
Standard
Approval Details
Approval Id
2326b6263b00de12
Drug Approval Philippines Name
Angitrim
Product Name
Angitrim
Registration Number
DRP-8586-10
Brand Name
Angitrim
Generic Name
Trimetazidine dihydrochloride
Dosage Form
Modified-Release Tablet
Dosage Strength
35 mg
Manufacturer
Stallion Laboratories Pvt. Ltd
Importer
Ambica International Corporation
Distributor
AGB Pharmaceutical Trading and Consultancy Corporation
Issuance Date
25 April 2024
Expiry Date
18 December 2029
Pharmacologic Category
Anti-Angina
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2326b6263b00de12
Type
Standard
Back to Philippines FDA Approvals